Cargando…

ACROBAT Edge: Safety and Efficacy of Switching Injected SRLs to Oral Paltusotine in Patients With Acromegaly

CONTEXT: Paltusotine is a once-daily, oral, nonpeptide small-molecule somatostatin receptor type 2 (SST2) agonist in clinical development for treatment of acromegaly. OBJECTIVE: This work aimed to evaluate change in insulin-like growth factor I (IGF-I) levels in patients switched from octreotide lon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gadelha, Monica R, Gordon, Murray B, Doknic, Mirjana, Mezősi, Emese, Tóth, Miklós, Randeva, Harpal, Marmon, Tonya, Jochelson, Theresa, Luo, Rosa, Monahan, Michael, Madan, Ajay, Ferrara-Cook, Christine, Struthers, R Scott, Krasner, Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Clinical Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099171/ https://www.ncbi.nlm.nih.gov/pubmed/36353760 http://dx.doi.org/10.1210/clinem/dgac643

Ejemplares similares

Safety and Efficacy of Switching Injected Peptide Long-Acting Somatostatin Receptor Ligands to Once Daily Oral Paltusotine: ACROBAT Edge Phase 2 Study
por: Gadelha, Monica R, et al.
Publicado: (2021)

OR01-01 Oral, Once-daily, Paltusotine (Non-peptide Selective Somatostatin Receptor Subtype 2 Agonist) Therapy In Patients With Acromegaly Is Associated With Long-term Biochemical And Symptom Control And Is Preferred Over Injectable Somatostatin-Receptor Ligands
por: Gadelha, Monica R, et al.
Publicado: (2023)

Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers
por: Madan, Ajay, et al.
Publicado: (2022)

Development and evaluation of the Acromegaly Symptom Diary
por: Martin, Susan, et al.
Publicado: (2023)

Prospect of acromegaly therapy: molecular mechanism of clinical drugs octreotide and paltusotine
por: Zhao, Jie, et al.
Publicado: (2023)

Clinical Management of Acromegaly: Therapeutic Frontiers and New Perspectives for Somatostatin Receptor Ligands (SRLs)
por: Brunetti, Alessandro, et al.
Publicado: (2022)

SAT628 Effect Of Hepatic Impairment On The Pharmacokinetics, Safety, And Tolerability Of Oral Paltusotine, A Non-peptide, Selective Somatostatin Receptor Subtype 2 Agonist
por: Luo, Rosa, et al.
Publicado: (2023)

Patient reported outcome data from acromegaly patients treated with injectable somatostatin receptor ligands (SRLs) in routine clinical practice
por: Geer, Eliza B., et al.
Publicado: (2020)

SAT-429 Final Results from the First in Man Phase 1 Clinical Trial of CRN00808, an Orally Bioavailable sst2-Selective, Nonpeptide Somatostatin Biased Agonist, for the Treatment of Acromegaly: Safety, Pharmacokinetics, Pharmacodynamics, and Midazolam Drug Interaction in Healthy Volunteers
por: Madan, Ajay, et al.
Publicado: (2019)

OR23-05 Human Absorption, Metabolism, Excretion, and Absolute Oral Bioavailability of (14)C-CRN00808, an Orally Bioavailable, Nonpeptide, Selective, Somatostatin Receptor 2 (sST2) Biased Agonist for the Treatment of Acromegaly
por: Madan, Ajay, et al.
Publicado: (2020)

Discovery of Paltusotine (CRN00808), a Potent, Selective, and Orally Bioavailable Non-peptide SST2 Agonist
por: Zhao, Jian, et al.
Publicado: (2022)

Editorial: Thyroid function and its interaction with metabolic molecules
por: Bodor, Miklós, et al.
Publicado: (2023)

Acrobat X
por: Deubert, John
Publicado: (2011)

Adobe Acrobat : superfácil
por: Córdoba González, Carmen
Publicado: (2002)

MON-323 IGF-I Variability and Its Association with Demographic and Clinical Characteristics in Patients with Acromegaly Treated with Injectable Somatostatin Receptor Ligands (SRLS); Results from an International Prospective Phase III Study
por: Samson, Susan Leanne, et al.
Publicado: (2020)

Deuteron Acrobatics at the ISR
Publicado: (1977)

Adobe Acrobat DC
por: Fridsma, Lisa, et al.
Publicado: (2015)

Acrobatic flexibility of the translocon
por: LeBrasseur, Nicole
Publicado: (2007)

Adobe Acrobat XI
por: Peachpit
Publicado: (2013)

Adobe Acrobat 7
por: Nakano, Shari
Publicado: (2005)

Adobe Acrobat 4.
Publicado: (2000)

Adobe Acrobat 7.
por: Adobe Press
Publicado: (2005)

Adobe Acrobat X
por: Sahlin, Doug
Publicado: (2011)

Acrobat 9 pro : superfácil /
por: Córdoba Moreno, Enrique
Publicado: (2010)

Adobe Acrobat 8 in the office
por: Baker, Donna L
Publicado: (2006)

Adobe Acrobat 7 in the office
por: Baker, Donna L
Publicado: (2005)

Acromegaly: Clinical Care in Central and Eastern Europe, Israel, and Kazakhstan
por: Bolanowski, Marek, et al.
Publicado: (2022)

The genetic background of acromegaly
por: Gadelha, Mônica R., et al.
Publicado: (2017)

Novel therapies for acromegaly
por: Maia, Bernardo, et al.
Publicado: (2020)

Adobe Acrobat X PDF Bible
por: Padova, Ted
Publicado: (2011)

Web publishing with Adobe Acrobat and PDF
por: Page, Bruce, et al.
Publicado: (1996)

Adobe Acrobat 9 for Windows and Macintosh
por: Deubert, John
Publicado: (2009)

Adobe Acrobat 8 for Windows and Macintosh
por: Deubert, John
Publicado: (2006)

Adobe Acrobat 8 PDF Bible
por: Padova, Ted
Publicado: (2008)

Adobe Acrobat 9 PDF Bible
por: Padova, Ted
Publicado: (2008)

Adobe Acrobat versión 3.0
Publicado: (1997)

Adobe Acrobat 7 for Windows and Macintosh
por: Alspach, Jennifer
Publicado: (2005)

The Structure of Selected Basic Acrobatic Jumps
por: Król, Henryk, et al.
Publicado: (2020)

Acromegaly and Colorectal Neoplasm: An Update
por: Kasuki, Leandro, et al.
Publicado: (2022)

Adobe Acrobat 4.0 : curso completo en un libro /
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_laia402teci4ktnhndln7gtqg0